Cover Image
Market Research Report

Point-of-Care Infectious Disease Diagnostics Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016-2024

Published by Coherent Market Insights Product code 629681
Published Content info 145 Pages
Delivery time: 2-3 business days
Price
Back to Top
Point-of-Care Infectious Disease Diagnostics Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016-2024
Published: April 17, 2018 Content info: 145 Pages
Description

Emerging economies such as Africa (West Africa), India, Brazil, and China have limited centralized laboratory facilities. In emerging economies point of care diagnostic is needed due to unavailability of labs, infrastructure, associated costs, and trained personnel. Most of the point-of-care diagnostic tests are comparatively easy to perform and can be performed with minimum amount of training. Infectious diseases such as HIV, Malaria, Tuberculosis, and others are highly prevalent in these emerging economies wherein point-of-care testing is a necessity. Furthermore, disease outbreaks are very frequent in these regions such as Yellow Fever disease outbreak in Nigeria and Brazil in December and November 2017, respectively and Acute Hepatitis E disease outbreak in Nigeria in July 2017, wherein point of care diagnostics could be helpful.

Market Dynamics

Technological advancements (innovative assays) to facilitate speedy diagnosis and extensive product portfolios of point of care infectious disease diagnostics offered by manufacturer's supports the growth of Point of Care Infectious Disease Diagnostics Market. Development of innovative point-of-care diagnostics for infectious diseases, wide applications in remote locations, constant disease outbreaks, and government funding for product development and research is expected to fuel growth of the market. The market is expected to gain significant growth, owing to increasing adoption of point-of-care diagnostics for infectious disease in remote locations, volume driven growth, and rising prevalence of infectious diseases such as HIV. Limited availability in emerging economies due to inventory issues and improper management, and result reliability issues are expected to hinder the market growth.

Key features of the study:

  • This report provides in-depth analysis of point of care infectious disease diagnostics market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017-2025), considering 2016 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global point of care infectious disease diagnostics market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key companies covered as a part of this study include Danaher Corporation, Abbott Laboratories, Acon Laboratories, Inc., Hoffman-La Roche Ltd., Becton, Dickinson, and Company, Trinity Biotech Plc, AccuBioTech Co., Ltd. and Cardinal Health, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global point of care infectious disease diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the point of care infectious disease diagnostics market

Detailed Segmentation:

  • Global Point of Care Infectious Disease Diagnostics Market, By Technology:
    • Lateral Flow
    • Agglutination Assays
    • Flow-Through
    • Solid Phase
  • Global Point of Care Infectious Disease Diagnostics Market, By Application:
    • HIV
    • Tropical Disease
    • Liver Disease
    • Inflammatory Disease
    • Respiratory Disease
    • Hospital Associated Infections (HAIs)
    • Sexual Health Disorders
    • Others
  • Global Point of Care Infectious Disease Diagnostics Market, By End User:
    • Hospitals
    • Diagnostic Laboratories
    • Home-Care Settings
    • Others
  • Global Point of Care Infectious Disease Diagnostics Market, By Geography:
    • North America
      • By Technology:
      • Lateral Flow
      • Agglutination Assays
      • Flow-Through
      • Solid Phase
      • By Application:
      • HIV
      • Tropical Disease
      • Liver Disease
      • Inflammatory Disease
      • Respiratory Disease
      • Hospital Associated Infections (HAIs)
      • Sexual Health Disorders
      • Others
      • By End User:
      • Hospitals
      • Diagnostic Laboratories
      • Home-Care Settings
      • Others
      • By Country:
      • U.S.
      • Canada
    • Europe
      • By Technology:
      • Lateral Flow
      • Agglutination Assays
      • Flow-Through
      • Solid Phase
      • By Application:
      • HIV
      • Tropical Disease
      • Liver Disease
      • Inflammatory Disease
      • Respiratory Disease
      • Hospital Associated Infections (HAIs)
      • Sexual Health Disorders
      • Others
      • By End User:
      • Hospitals
      • Diagnostic Laboratories
      • Home-Care Settings
      • Others
      • By Country:
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Technology:
      • Lateral Flow
      • Agglutination Assays
      • Flow-Through
      • Solid Phase
      • By Application:
      • HIV
      • Tropical Disease
      • Liver Disease
      • Inflammatory Disease
      • Respiratory Disease
      • Hospital Associated Infections (HAIs)
      • Sexual Health Disorders
      • Others
      • By End User:
      • Hospitals
      • Diagnostic Laboratories
      • Home-Care Settings
      • Others
      • By Country:
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
    • Latin America
      • By Technology:
      • Lateral Flow
      • Agglutination Assays
      • Flow-Through
      • Solid Phase
      • By Application:
      • HIV
      • Tropical Disease
      • Liver Disease
      • Inflammatory Disease
      • Respiratory Disease
      • Hospital Associated Infections (HAIs)
      • Sexual Health Disorders
      • Others
      • By End User:
      • Hospitals
      • Diagnostic Laboratories
      • Home-Care Settings
      • Others
      • By Country:
      • Brazil
      • Mexico
      • Rest of Latin America
    • Middle East
      • By Technology:
      • Lateral Flow
      • Agglutination Assays
      • Flow-Through
      • Solid Phase
      • By Application:
      • HIV
      • Tropical Disease
      • Liver Disease
      • Inflammatory Disease
      • Respiratory Disease
      • Hospital Associated Infections (HAIs)
      • Sexual Health Disorders
      • Others
      • By End User:
      • Hospitals
      • Diagnostic Laboratories
      • Home-Care Settings
      • Others
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Technology:
      • Lateral Flow
      • Agglutination Assays
      • Flow-Through
      • Solid Phase
      • By Application:
      • HIV
      • Tropical Disease
      • Liver Disease
      • Inflammatory Disease
      • Respiratory Disease
      • Hospital Associated Infections (HAIs)
      • Sexual Health Disorders
      • Others
      • By End User:
      • Hospitals
      • Diagnostic Laboratories
      • Home-Care Settings
      • Others
      • By Country:
      • Central Africa
      • South Africa
      • North Africa
  • Company Profiles
    • Danaher Corporation*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
    • Abbott Laboratories
    • Acon Laboratories, Inc.
    • Hoffman-La Roche Ltd.
    • Becton, Dickinson, and Company
    • Trinity Biotech Plc
    • AccuBioTech Co., Ltd.
    • Cardinal Health, Inc.
  • "*" marked represents similar segmentation in other categories in the respective section.
Table of Contents

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Technology
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • PEST Analysis

4. Global Point of Care Infectious Disease Diagnostics Market, By Technology, 2015 - 2025 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2016 and 2025 (%)
    • Y-o-Y Growth Analysis, 2016 - 2025
    • Segment Trends
  • Lateral Flow
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Mn)
  • Agglutination Assays
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Mn)
  • Flow-Through
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Mn)
  • Solid Phase
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Mn)

5. Global Point of Care Infectious Disease Diagnostics Market, By Application, 2015 - 2025 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2016 and 2025 (%)
    • Y-o-Y Growth Analysis, 2016 - 2025
    • Segment Trends
  • HIV
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Mn)
  • Tropical Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Mn)
  • Liver Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Mn)
  • Inflammatory Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Mn)
  • Respiratory Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Mn)
  • Hospital Associated Infections (HAIs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Mn)
  • Sexual Health Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Mn)

6. Global Point of Care Infectious Disease Diagnostics Market, By End User, 2015 - 2025 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2016 and 2025 (%)
    • Y-o-Y Growth Analysis, 2016 - 2025
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Mn)
  • Home-Care Settings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Mn)
  • Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Mn)

7. Global Point of Care Infectious Disease Diagnostics Market, By Regions, 2015 - 2025 (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2016 and 2025 (%)
    • Y-o-Y Growth Analysis, For Regions, 2016 - 2025
  • North America
    • Market Size and Forecast, By Technology, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By Application, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By End User, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
    • U.S.
    • Canada
  • Europe
    • Market Size and Forecast, By Technology, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By Application, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By End User, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Technology, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By Application, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By End User, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Market Size and Forecast, By Technology, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By Application, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By End User, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Technology, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By Application, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By End User, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
    • Central Africa
    • South Africa
    • North Africa
  • Middle East
    • Market Size and Forecast, By Technology, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By Application, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By End User, 2015 - 2025 (US$ Mn)
    • Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East

8. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • Danaher Corporation
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Abbott Laboratories
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Acon Laboratories, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Hoffman-La Roche Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Becton, Dickinson, and Company
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Trinity Biotech Plc
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • AccuBioTech Co., Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Cardinal Health, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

9. Section

  • References
  • Research Methodology
  • About us and Sales Contact
Back to Top